Regulation & Industry Affairs

Roundstone Sets 2027 Medical Captive Forum for Nashville, May 11-12

Image
Roundstone Sets 2027 Medical Captive Forum for Nashville, May 11-12

Rocky River, Ohio – September 14, 2026 -- Roundstone Insurance will hold its annual Medical Captive Forum (MCF) on May 11 and 12, 2027, in Nashville, Tennessee, bringing together hundreds of employer executives to tackle rising health plan costs.

Event targets employers moving away from fully insured health models

The complimentary two-day forum will gather CEOs, CFOs, HR leaders, benefits advisors, and healthcare innovators to discuss redesigning health plans for greater transparency, cost control, and long-term sustainability. Sessions will cover plan design, captive insurance structures, and cost containment strategies through panels, roundtables, and networking.

Roundstone reimburses attendees for lodging costs

Beyond complimentary programming, Roundstone will reimburse employers for one night's hotel stay, lowering the barrier for mid-market companies to attend.

German Science Bodies Demand Cross-Ministry Health Prevention Strategy

Berlin – September 13, 2026 -- Four of Germany's leading scientific and health organizations have issued a joint call for a cross-departmental national prevention strategy, warning that roughly 40 percent of new cancer cases remain preventable despite decades of research.

Four organizations unite behind a joint policy statement

The Leopoldina National Academy of Sciences, the German Council of Science and Humanities (Wissenschaftsrat), the German Cancer Research Center (DKFZ) and German Cancer Aid (Deutsche Krebshilfe) presented a shared statement demanding that prevention be embedded across all policy fields -- including education, labor, transport, urban planning, environment and social affairs -- rather than confined to the health ministry alone.

Eligible Passes SOC 2 Type II With Zero Exceptions

Image
Eligible Passes SOC 2 Type II With Zero Exceptions

New York – September 12, 2026 -- Eligible, Inc. has completed its SOC 2 Type II examination for its Platform Services System with zero exceptions across all four Trust Services Categories evaluated: Security, Availability, Processing Integrity, and Confidentiality.

Independent assessor A-LIGN confirms full compliance across audit period

The examination, conducted by third-party assessor A-LIGN, evaluated the design and operating effectiveness of Eligible's controls over a defined audit period, covering the REST APIs, application infrastructure, and supporting services that process HIPAA-mandated healthcare financial transactions. These include eligibility verification (270/271), claims (837/276/277), remittance (835), and acknowledgements (TA1, 997, 999).

Curaleaf Rebuts Aurora Cannabis Claims, Defends Takeover Premium

Stamford, Conn. – – September 12, 2026 -- Curaleaf Holdings, Inc. released a fact sheet countering what it called inaccurate statements by Aurora Cannabis Inc. regarding Curaleaf's proposal to acquire the company, arguing its offer represents one of the highest premiums in a decade of Canadian M&A.

Curaleaf says its bid carries a 110% premium once Aurora's cash is excluded

Curaleaf's headline offer reflects a 45% premium, which the company says ranks among the higher Canadian M&A premiums of the past ten years. Stripping out cash on Aurora's balance sheet, Curaleaf calculates the effective premium at 110%. Curaleaf noted Aurora has continued issuing shares through an At-the-Market program at prices below the value implied by the offer, even after the bid was made public.

German Medical Association Backs Emergency Care Reform, Demands Changes

Berlin – September 12, 2026 -- Germany's Federal Medical Association (Bundesärztekammer) has confirmed support for a cross-sector reform of acute and emergency care, while pushing for amendments before the bill clears parliament.

Reinhardt calls for unified triage system across Germany

Association president Dr. Klaus Reinhardt told the Bundestag Health Committee ahead of a hearing on the draft law that the reform must introduce "genuine care management" needed across other healthcare sectors too. He said a nationwide, standardized initial assessment system is required to ensure patients are directed reliably through the system, with responsibility resting with physician self-governance bodies.

German Hospital Chief Physician Earns European Emergency Medicine Credential

Image
German Hospital Chief Physician Earns European Emergency Medicine Credential

Frankfurt (Oder) – September 10, 2026 -- Dr. Dominik Treffer, chief physician of the Clinic for Acute and Emergency Medicine at Klinikum Frankfurt (Oder) since June 2026, has passed the examination for the European Specialist in Emergency Medicine, adding an internationally recognized credential to his qualifications as a specialist in anesthesiology with additional certifications in emergency medicine and clinical acute and emergency medicine.

Germany still lacks a standalone emergency medicine specialty recognized across many European countries

Unlike numerous European countries with an independent emergency medicine specialty, Germany has no equivalent formal credential. Care for acutely ill and injured patients in the country's central emergency departments is currently handled by physicians from a range of different medical specialties, making structured additional qualification in clinical emergency medicine increasingly significant.

Beta Bionics Faces Class Action Over iLet Insulin Pump Disclosures

Image
Beta Bionics Faces Class Action Over iLet Insulin Pump Disclosures

San Diego – September 10, 2026 -- Robbins LLP has filed a securities class action against Beta Bionics, Inc. (NASDAQ: BBNX) on behalf of investors who purchased common stock between July 30, 2025 and February 24, 2026, alleging the company misrepresented the safety and commercial viability of its iLet Bionic Pancreas insulin pump.

FDA warning letter contradicts prior company statements on device complaints

The complaint alleges that in October 2025, Beta Bionics disclosed an FDA Form 483 but told investors the issue was limited to complaint-reporting classification, not device safety, and that only minor customer complaints needed backfiling. Plaintiffs allege the FDA had in fact identified device malfunctions causing dangerously high insulin dosing and hypoglycemic events, with complaints numbering in the thousands and hundreds involving life-threatening incidents requiring medical intervention.

Hims & Hers Faces Securities Suit After FTC Data-Sharing Complaint

Image
Hims & Hers Faces Securities Suit After FTC Data-Sharing Complaint

San Francisco – September 10, 2026 -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain executives now face a securities class action after a July 29, 2026 federal complaint from the Federal Trade Commission wiped over $970 million from the company's market capitalization in a single trading session, sending shares down $4.32, or 14.7%.

FTC alleges Hims shared health data with Meta and Snap despite privacy pledges

The FTC complaint, filed alongside co-plaintiffs the State of Utah and Los Angeles County representing California, accuses Hims of surreptitiously sharing sensitive user medical conditions and personal health data with third-party advertising platforms including Meta Platforms and Snap. Regulators allege the company used embedded tracking pixels and customer list matching to transmit this data, contradicting public assurances that it maintained administrative, physical, and technical safeguards for health and personal information.

ABDA Sets Munich Press Briefing on Pharmacy Reform Impact

Image
ABDA Sets Munich Press Briefing on Pharmacy Reform Impact

Munich – September 10, 2026 -- More than 300 delegates from Germany's 17 pharmacist chambers and associations will convene in Munich from September 15 to 17 for the German Pharmacists' Day (Deutscher Apothekertag, DAT) 2026, as the country's pharmacy reform moves from legislation into implementation.